Pharma Industry News

Novartis to sell parts of Sandoz to India’s Aurobindo

Novartis has announced that it will sell its Sandoz U.S. dermatology business and generic U.S. oral solids portfolio to India’s Aurobindo Pharma.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]